CLOSED
GET A PIECE OF MEDVECTOR
A clinical trial could save your life…
Show more
REASONS TO INVEST
TEAM
Scott Stout • CEO, Board Member & Founder
Read More
Ted Barduson • Chief Operating Officer, Board Member & Co-Founder
Dr. Dennis Patterson • Hospital Relations, Board Member & Co-Founder
ABOUT
HEADQUARTERS
898 N. Pacific Coast Highway
El Segundo, CA 90245
WEBSITE
View Site
TERMS
MedVector
Overview
INTEREST RATE
4.8%
MATURITY DATE
May 1, 2026
DEADLINE
Aug. 20, 2024 at 6:59 AM UTC
VALUATION CAP
$25M
FUNDING GOAL
$15K - $618K
Breakdown
MIN INVESTMENT
$500
DISCOUNT
12.0%
CONVERSION TRIGGER
$3,000,000
OFFERING TYPE
Convertible Notes
TYPE OF EQUITY
Common Stock
A convertible note offers you the right to receive Common Stock in MedVector. The amount of Common Stock you will receive in the future will be determined at the next equity round in which the Company raises at least $3,000,000.00 in a qualified equity financing. The highest conversion price per security is set based on a $25,000,000.00 Valuation Cap or if less, then you will receive a 12.00% discount on the price the new investors are paying. You also receive 4.85% interest per year added to your investment. When the maturity date is reached, if the note has not converted then you are entitled to receive Common Stock equal to your investment and interest back at a price per security determined by dividing the Valuation Cap by the aggregate number of outstanding equity securities of the Company as of immediately prior (on a fully diluted basis).
*Annual Interest Rate subject to adjustment of 10% bonus for StartEngine shareholders. See 10% Bonus below.
Voting Rights of Securities Sold in this Offering
Voting Proxy. Should the convertible promissory notes sold in this offering convert into shares of Common Stock, each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.
Investment Incentives and Bonuses*
Loyalty Bonus | 20% Bonus Interest
As you are an existing investor in MedVector, you are eligible for additional bonus interest.
Time-Based Investment Incentives
Early Bird
Invest within the first two weeks and receive 10% bonus interest.
*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus interest from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed. Crowdfunding investments made through a self-directed IRA cannot receive perks due to tax laws. The Internal Revenue Service (IRS) prohibits self-dealing transactions in which the investor receives an immediate, personal financial gain on investments owned by their retirement account. As a result, an investor must refuse those perks because they would be receiving a benefit from their IRA account.
The 10% StartEngine Venture Club
MedVector Corp. will offer a 10% additional bonus interest for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding, Inc. Venture Club bonus.
Eligible StartEngine convertible note holders will receive a 10% increase in the annual interest rate on Convertible Promissory Notes in this Offering. This means your annual interest rate will be 5.335% instead of 4.85%.
This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Eligible investors will also receive the Venture Club Bonus and the Loyalty Bonus in addition to the Early Bird bonus.
Irregular Use of Proceeds
ALL UPDATES
08.19.24
Less Than 24 Hours Left to Invest in MedVector!
The clock is ticking! Our funding round closes in less than 24 hours. This is your final opportunity to invest in MedVector share in our future success.
Don’t miss out – Click on the image before it’s too late!
Invest Now / Learn More: https://www.startengine.com/offering/medvector
08.16.24
Less Than 3 Days Left to Invest in Medvector
Less than 3 days remain for you to own a piece of the company that’s transforming the $1.6T pharma industry! Tired of pharma always winning? Invest in MedVector and be part of the solution.
Invest Now: https://www.startengine.com/offering/medvector
08.16.24
Top Pharma Companies Have Noticed MedVector
MedVector has secured NDAs with 9 of the top 15 pharmaceutical companies. This makes MedVector ideally positioned to move on upcoming FDA Guidance. Don’t miss your chance to invest in a company with strong industry awareness!
Invest Now / Learn More: https://www.startengine.com/offering/medvector
08.15.24
Pharma needs us, and we need you!
MedVector is combating high drug prices by addressing the delays in critical trials. By leveraging telemedicine, we bridge the gap between patients who need advanced treatments and pharma who need patients to prove efficacy of cutting edge medical breakthroughs!
Help us solve this vital problem by investing today!
Invest Now / Learn More: https://www.startengine.com/offering/medvector
08.14.24
$3.5 Million Raised to date
MedVector has raised $3.5 million to date. Breaking into the pharmaceutical industry requires capital and longevity. We’ve already developed our sales prototypes, cloud-based telemedicine platform, and became thought-leaders. Join us just before the finish line!
Invest Now / Learn More: https://www.startengine.com/offering/medvector
08.12.24
Final week to be an investor in something BIG...
We’re in the final week of this opportunity for our friends and family! We’ve allocated only $600k and it’s going fast. Don’t let this opportunity pass you by – invest today and be part of the future of healthcare.
Invest Now / Learn More: https://www.startengine.com/offering/medvector
08.07.24
Accelerating Drugs to Market
MedVector's innovative approach eliminates the costly delays of getting new drugs to market. Our telemedicine platform opens access to anyone that can benefit from advanced medicine through a clinical trial. The result is faster access to life-saving treatments for anyone regardless of where they live or their socioeconomic status.
Join us in this revolutionary advancement. Invest now!
Invest Now / Learn More: https://www.startengine.com/offering/medvector
08.05.24
A wave of healthcare innovation is coming!
New technological breakthroughs are on the horizon. AI is identifying new ways to apply these breakthroughs from stem-cell research, to gene-sequencing, but what do they all have in common? New drugs from these technologies will all require clinical trials before getting into the hands of the people who need them!
MedVector’s innovative telemedicine platform is set to transform how patients access clinical trials. Don’t miss your chance to invest in the future of healthcare.
Invest Now / Learn More: https://www.startengine.com/offering/medvector
08.02.24
A $1.6 Trillion Industry is ready…
MedVector is making waves in the $1.6 trillion pharmaceutical industry. With 105 NDAs signed, including 9 of the top 15 pharmaceutical companies, our traction is undeniable. Join us on this exciting journey and invest in our future success!
Invest Now / Learn More: https://www.startengine.com/offering/medvector
07.31.24
Less Than 19 Days to Invest in MedVector
Time is running out! There is limited space remaining in MedVector's friends and family convertible note. This is your last chance to invest in a company disrupting the $1.6T pharmaceutical industry.
Invest Now / Learn More: https://www.startengine.com/offering/medvector
REWARDS
10%
Stack Venture Club & Rewards!
Members get an extra 10% interest rate in addition to rewards below!
Venture Club
Venture Club Members earn 10% bonus interest rate on top of this and all eligible investments for an entire year. Not a member? Sign up at checkout ($275/year).
JOIN THE DISCUSSION
0/2500
HOW INVESTING WORKS
Cancel anytime before 48 hours before a rolling close or the offering end date.
WHY STARTENGINE?
REWARDS
We want you to succeed and get the most out of your money by offering rewards and memberships!
SECURE
Your info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTS
Invest in over 200 start-ups and collectibles!
FAQS
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000 are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, they are limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancellation period. Once the four-hour window has passed, it is up to each company to set their own cancellation policy. You may find the company’s cancellation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to be sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
